Peter Novota

759 total citations
32 papers, 592 citations indexed

About

Peter Novota is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Peter Novota has authored 32 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Peter Novota's work include Diabetes and associated disorders (10 papers), Immune Cell Function and Interaction (9 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). Peter Novota is often cited by papers focused on Diabetes and associated disorders (10 papers), Immune Cell Function and Interaction (9 papers) and Inflammatory Myopathies and Dermatomyositis (9 papers). Peter Novota collaborates with scholars based in Czechia, United Kingdom and Germany. Peter Novota's co-authors include Ralf Dressel, Leslie Elsner, Michal Anděl, Katarína Kološtová, Jan Novák, Marie Černá, J Skibová, F Saudek, Petr Bouček and Tereza Havrdova and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The FASEB Journal.

In The Last Decade

Peter Novota

32 papers receiving 578 citations

Peers

Countries citing papers authored by Peter Novota

Since Specialization

Citations

This map shows the geographic impact of Peter Novota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Novota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Novota more than expected).

Fields of papers citing papers by Peter Novota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Novota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Novota. The network helps show where Peter Novota may publish in the future.

Co-authorship network of co-authors of Peter Novota

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Novota. A scholar is included among the top collaborators of Peter Novota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Novota. Peter Novota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations 2014 ·The Journal of Rheumatology ·Martin Klein, H. Mann, Lenka Pleštilová, Zoë Betteridge, Neil McHugh, (unknown), Peter Novota, Jiří Vencovský	19
2	A3.29 Micro-RNA molecules are clearly involved in pathogenesis of idiopathic inflammatory myopathy 2014 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Lenka Pleštilová, H. Mann, Peter Novota, Jiří Vencovský	1
3	SAT0188 Clinical and Ultrasonographic Characteristics of Arthritis in Patients with Idiopathic Inflammatory Myopathies 2013 ·Annals of the Rheumatic Diseases ·Martin Klein, H. Mann, Petra Hánová, Lenka Pleštilová, Jakub Závada, (unknown), Peter Novota, Jiří Vencovský	1
4	Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease 2011 ·PLoS ONE ·Peter Novota, (unknown), Jean Norden, Xiao Nong Wang, Lisbet Sviland, Lennart Opitz, Gabriela Salinas-Riester, Bent Rolstad, Anne M. Dickinson, Lutz Walter, Ralf Dressel	11
5	HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population 2010 ·Rheumatology International ·(unknown), Peter Novota, (unknown), (unknown), Dana Tegzová, Marie Černá	17
6	Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells 2010 ·The FASEB Journal ·Ralf Dressel, Jessica Nolte, Leslie Elsner, Peter Novota, Kaomei Guan, Katrin Streckfuß‐Bömeke, Gerd Hasenfuß, Rudolf Jaenisch, Wolfgang Engel	78
7	HLA-Cw06 class I region rather than MICA is associated with psoriatic arthritis in Czech population 2009 ·Rheumatology International* ·(unknown), (unknown), Peter Novota, (unknown), C Dostál, Marie Černá	9
8	Correlation of Hsp70-1 and Hsp70-2 Gene Expression With the Degree of Graft-Versus-Host Reaction in a Rat Skin Explant Model 2008 ·Transplantation ·Peter Novota, Lisbet Sviland, (unknown), Paweł Stocki, Yesilda Balavarca, Heike Bickeböller, Bent Rolstad, Xiao N. Wang, Anne M. Dickinson, Ralf Dressel	13
9	The Tumorigenicity of Mouse Embryonic Stem Cells and In Vitro Differentiated Neuronal Cells Is Controlled by the Recipients' Immune Response 2008 ·PLoS ONE ·Ralf Dressel, (unknown), Tanja Kuhlmann, Leslie Elsner, Peter Novota, Paul Christian Baier, Arne Schillert, Heike Bickeböller, Thomas Herrmann, Claudia Trenkwalder, Walter Paulus, Ahmed Mansouri	85
10	HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult‐onset diabetes mellitus in Czech patients 2008 ·International Journal of Immunogenetics ·(unknown), Peter Novota, (unknown), Katarína Kološtová, (unknown), Petr Kučera, Jan Novák, Michal Anděl, Pavel Weber, E Zďárský	14
11	KCNJ11 E23K Polymorphism and Diabetes Mellitus with Adult Onset in Czech Patients 2007 ·Folia Biologica ·(unknown), Peter Novota, M Černá, Katarína Kološtová, (unknown), Petr Kučera, Jan Novák, Michal Anděl, Pavel Weber, E Zďárský	22
12	Autoimmune Diabetes Mellitus with Adult Onset and Type 1 Diabetes Mellitus in Children Have Different Genetic Predispositions 2007 ·Annals of the New York Academy of Sciences ·Marie Černá, Katarína Kološtová, Peter Novota, Marianna Romžová, (unknown), Daniela Pintérová, Štěpánka Průhová, (unknown), Michal Anděl	7
13	Polymorphism of interleukin‐18 promoter influences the onset of kidney graft function after transplantation 2007 ·Tissue Antigens ·Libor Kolesár, Peter Novota, (unknown), Antonij Slavčev, Ondřej Viklický, Eva Honsová, (unknown)	18
14	Association of MHC class I chain related gene‐A microsatellite polymorphism with the susceptibility to T1DM and LADA in Czech adult patients 2005 ·International Journal of Immunogenetics ·Peter Novota, Katarína Kološtová, Daniela Pintérová, Jan Novák, Pavel Weber, (unknown), (unknown), Michal Anděl, (unknown)	11
15	Fluorescence-Based Automated Fragment Analysis of Microsatellite Polymorphism within the Transmembrane Region of the MIC-A Gene 2004 ·Folia Biologica ·Peter Novota, Libor Kolesár, Antonij Slavčev, Marie Černá	6
16	Diabetes mellitus in adults: association of HLA DRB1 and DQB1 diabetes risk alleles with GADab presence and C-peptide secretion 2004 ·Immunology Letters ·Peter Novota, Marie Černá, Katarína Kološtová, (unknown), (unknown), Dana Nováková, Petr Kučera, Jan Novák, Michal Anděl	4
17	Polyclonal Anti-T-Cell Therapy for Type 1 Diabetes Mellitus of Recent Onset 2004 ·The Review of Diabetic Studies ·F Saudek, Tereza Havrdova, Petr Bouček, L Karasová, Peter Novota, J Skibová	57
18	The Frequency of Alleles of the Pro12Ala Polymorphism in PPARγ2 Is Different between Healthy Controls and Patients with Type 2 Diabetes 2004 ·Folia Biologica ·Daniela Pintérová, Marie Černá, Katarína Kološtová, Peter Novota, (unknown), Marianna Romžová, Aleš Kuběna, Michal Anděl	3
19	HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes 2003 ·European Journal of Immunogenetics ·(unknown), Peter Novota, Katarína Kološtová, (unknown), E Zďárský, Dana Nováková, Petr Kučera, Jan Novák, Michal Anděl	30
20	[Methods for identification of HLA antigen polymorphisms]. 2002 ·PubMed ·Peter Novota, Marie Černá, Michal Anděl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact